Technical Analysis for ERYP - Erytech Pharma S.A.

Grade Last Price % Change Price Change
F 6.905 -1.78% -0.13
ERYP closed down 1.78 percent on Friday, April 16, 2021, on 8 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ERYP trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Resistance Bearish -1.78%
Death Cross Bearish -1.78%
Bollinger Band Squeeze Range Contraction -1.78%
Narrow Range Bar Range Contraction -1.78%
NR7 Range Contraction -1.78%
Bollinger Band Squeeze Range Contraction -1.07%
BB Squeeze + Lower Band Touch Range Contraction -1.07%
Inside Day Range Contraction -1.07%
Lower Bollinger Band Touch Weakness -1.07%
Older End-of-Day Signals for ERYP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Erytech Pharma S.A. Description

Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The Company's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death. The Company's subsidiary is Erytech Pharma, Inc in the USA which legal existence began in April 9, 2014.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Immunology Hematology Enzymes Antineoplastic Drugs Cancer Cell Leukemia Childhood Red Blood Cell Acute Lymphoblastic Leukemia Blood Cells Medicinal Product Asparaginase Childhood Cancer Medicinal Products

Is ERYP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 13.95
52 Week Low 3.5
Average Volume 15,948
200-Day Moving Average 8.11
50-Day Moving Average 8.00
20-Day Moving Average 7.05
10-Day Moving Average 7.01
Average True Range 0.45
ADX 37.36
+DI 12.51
-DI 24.37
Chandelier Exit (Long, 3 ATRs ) 6.33
Chandelier Exit (Short, 3 ATRs ) 7.84
Upper Bollinger Band 7.42
Lower Bollinger Band 6.67
Percent B (%b) 0.31
BandWidth 10.65
MACD Line -0.28
MACD Signal Line -0.35
MACD Histogram 0.0654
Fundamentals Value
Market Cap 131.74 Million
Num Shares 19.1 Million
EPS -2.79
Price-to-Earnings (P/E) Ratio -2.48
Price-to-Sales 0.00
Price-to-Book 2.98
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.29
Resistance 3 (R3) 7.28 7.15 7.22
Resistance 2 (R2) 7.15 7.05 7.15 7.20
Resistance 1 (R1) 7.03 6.99 6.96 7.03 7.18
Pivot Point 6.89 6.89 6.86 6.89 6.89
Support 1 (S1) 6.77 6.79 6.70 6.78 6.63
Support 2 (S2) 6.64 6.73 6.64 6.61
Support 3 (S3) 6.52 6.64 6.59
Support 4 (S4) 6.52